Skip to main content
Fig. 1 | Diagnostic Pathology

Fig. 1

From: Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma

Fig. 1

Comparison of PD-L1 assays for UC and differences in immune cell measurement and scoring algorithm. *Ratio of tumor cells (TC) and immune cells (IC) relative to number of all TC. †IC score is the percentage area of ICs present exhibiting PD-L1 positive IC staining. ‡IC score is the proportion of ICs that are PD-L1 positive, expressed in relation to tumor area. CE European Conformity, Cis cisplatin, IVD in vitro diagnostic

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us